| Customization: | Available |
|---|---|
| CAS No.: | 22457-89-2 |
| Formula: | C19h23n4o6PS |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
|
Product Name: Benfotiamine CAS No: 22457-89-2 EINECS No.: 245-013-4 Molecular Formular: C19H23N4O6PS Molecular Weight: 466.4479 Solubility: Insoluble in water |
Benfotiamine is useful for the treatment of diabetic retinopathy, neuropathy, and nephropathy however "Most of the effects attributed to benfotiamine are extrapolated from in vitro and animal studies. Unfortunately apparent evidences from human studies are scarce and especially endpoint studies are missing. Therefore additional clinical studies are mandatory to explore the therapeutic potential of benfotiamine in both diabetic and non-diabetic pathological conditions".
|
Items |
Specification |
|
Appearance |
Pale-yellow or white powder |
|
Identification |
Positive reaction |
|
Solution color and clearness |
Colorless to pale-yellow clear solution |
|
chlorides |
≤0.053% |
|
sulphate |
≤0.011% |
|
Heavy metal |
≤0.002% |
|
Loss on drying |
≤1.5% |
|
thiamine |
≤0.1% |
|
Benzoic acid |
≤0.1% |
|
Assay |
98.0%-102.0% |
A.Iis used for the prevention and treatment of vitamin B1 deficiency;
B. For vitamin B1 demand increase, with inadequate intake from foods supplies (fatigue, hyperthyroidism, pregnancy, lactation, during strenuous manual labor, etc.);
C. Is used in the treatment of non alcoholic wernicke encephalopathy;
D. To treat beriberi;
E. Used in the following diseases, speculation and vitamin B1 deficiency and metabolic disorders associated with treatment, such as: neuralgia; Muscle pain, joint pain; Peripheral neuritis, peripheral nerve palsy; Myocardial metabolic disorders; Constipation and other gastrointestinal motor function obstacle.
){kind=link}